Survival Signaling After Genotoxic Insult
基因毒性侮辱后的生存信号
基本信息
- 批准号:6867502
- 负责人:
- 金额:$ 28.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:DNA damageRNA interferenceRNase protection assaybiological signal transductioncarcinogenesiscell cyclecell growth regulationchemical carcinogenchromiumenvironmental exposurefibroblastsflow cytometrygene induction /repressionhuman tissueimmunocytochemistrylung neoplasmsphosphorylationposttranslational modificationsprotein tyrosine kinaserespiratory epitheliumserine threonine protein kinasesmall interfering RNAtransfectionwestern blottings
项目摘要
DESCRIPTION (provided by applicant): Inappropriate activation/inactivation of key signals that control cell survival after genotoxic insult can contribute to autonomous growth and neoplastic transformation. An initial consequence of genotoxic injury is cell cycle checkpoint arrest but genotoxicity may also activate cell death pathways of apoptosis or terminal growth arrest. Cellular survival responses to genotoxic insult may produce intrinsic death-resistance; such a selective growth advantage may allow for emergence of a transformed phenotype. Certain forms of hexavalent chromium [(Cr(VI)] are known human respiratory carcinogens that can be employed as useful genotoxic tools with relevant toxicological importance. Our preliminary studies suggest that maintenance of protein tyrosine phosphorylation, which is coincident with AKT activation, overrides Cr-induced growth arrest and enhances clonogenic survival. Constitutive AKT activation is known to play an important role in carcinogenesis. Therefore, the overall objective of this proposal is to elucidate the coordinate signaling events that mediate cell fate determination and survival after genotoxic insult. The dual overarching hypotheses of the proposed studies are that: 1) AKT activation shifts the balance of cell fates, toward survival, after Cr(Vl) genotoxic insult; and 2) AKT activation in the face of Cr(Vl) genotoxic insult increases genomic instability. To test these hypotheses, we will employ molecular, pharmacological and genetic approaches, by using relevant model systems of human diploid lung fibroblasts (HLF), and human large airway epithelial cells (HLAE) and studying the involvement of key signaling components of the AKT pathway. The molecular circuitry of the AKT effect will be delineated in Aim 1, and the consequences of an AKT-induced "override" of the genotoxin-elicited program of cell death will be investigated in Aim 2. Aim 3 will identify the role of AKT in resistance to Cr(Vl)-induced clonogenic lethality in a subclonal population of cells with acquired resistance to Cr-induced clonogenic death. We will use soluble Na2CrO4 at a range of concentrations relevant to human exposure, and for which the DNA adduct frequencies and genotoxic lesions are well documented. Results of the proposed studies will identify molecular mechanism(s) that confer a growth advantage to cells after genotoxic insult, and add new insights to the understanding of Cr(Vl)-induced lung carcinogenesis, while addressing a need for sensitive and specific molecular indices that can be correlated with exposure to carcinogenic agents, as well as with their cancer incidence. Delineation of the molecular circuitry involved in AKT survival signaling may have the added benefit of identifying molecular targets for rational drug design in anti-cancer therapy.
描述(由申请人提供):基因毒性损伤后控制细胞存活的关键信号的不适当激活/失活可能有助于自主生长和肿瘤转化。基因毒性损伤的最初后果是细胞周期检查点停滞,但基因毒性也可能激活细胞凋亡或终末生长停滞的细胞死亡途径。细胞对基因毒性损伤的生存反应可能会产生内在的死亡抵抗力;这种选择性生长优势可能会导致转化表型的出现。某些形式的六价铬 [(Cr(VI)] 是已知的人类呼吸道致癌物,可用作具有相关毒理学重要性的有用基因毒性工具。我们的初步研究表明,与 AKT 激活同时发生的蛋白质酪氨酸磷酸化的维持会覆盖 Cr已知 AKT 诱导的生长停滞和增强克隆存活在癌发生中发挥重要作用。协调介导细胞命运决定和基因毒性损伤后存活的信号事件所提出的研究的双重总体假设是:1) AKT 激活在 Cr(VI) 基因毒性损伤后改变细胞命运的平衡,转向存活; 2) 面对 Cr(VI) 基因毒性损伤时 AKT 激活会增加基因组不稳定性。为了检验这些假设,我们将采用分子、药理学和遗传学方法,通过使用人二倍体肺成纤维细胞(HLF)和人大气道上皮细胞(HLAE)的相关模型系统,并研究 AKT 通路关键信号成分的参与。目标 1 将描述 AKT 效应的分子回路,目标 2 将研究 AKT 诱导“覆盖”基因毒素引起的细胞死亡程序的后果。目标 3 将确定 AKT 在对 Cr(VI) 诱导的克隆致死性具有抗性的细胞亚克隆群体中具有对 Cr(VI) 诱导的克隆致死的获得性抗性。我们将使用与人体暴露相关的一系列浓度的可溶性 Na2CrO4,并且其 DNA 加合物频率和基因毒性损伤都有详细记录。拟议研究的结果将确定在基因毒性损伤后赋予细胞生长优势的分子机制,并为理解 Cr(VI) 诱导的肺癌发生提供新的见解,同时解决对敏感和特定分子指数的需求这可能与接触致癌物质及其癌症发病率有关。描绘 AKT 生存信号传导所涉及的分子电路可能具有额外的好处,可以识别抗癌治疗中合理药物设计的分子靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN M CERYAK其他文献
SUSAN M CERYAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN M CERYAK', 18)}}的其他基金
Mechanisms of particulate chromium lung carcinogenesis
颗粒铬肺癌发生机制
- 批准号:
8125032 - 财政年份:2010
- 资助金额:
$ 28.23万 - 项目类别:
Mechanisms of particulate chromium lung carcinogenesis
颗粒铬肺癌发生机制
- 批准号:
7990590 - 财政年份:2010
- 资助金额:
$ 28.23万 - 项目类别:
相似国自然基金
长链非编码RNA LncLsm3a通过调控NS1蛋白干扰素拮抗功能促进A型流感病毒感染和复制的分子机制
- 批准号:32302957
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
外泌体-小干扰RNA体系的构建及其调控肿瘤微环境的机制与应用研究
- 批准号:32371448
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
RNA干扰和白细胞介素-2联合治疗慢性乙型肝炎的效应和机制研究
- 批准号:82302505
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA结合蛋白KHSRP通过调控mRNA剪接抑制I型干扰素信号通路的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:
长链非编码RNA AATBC结合并干扰SRSFs蛋白发生相分离调控RNA可变剪接促进三阴性乳腺癌耐药的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Genome-wide Investigation of cis-splicing between Adjacent Genes
相邻基因之间顺式剪接的全基因组研究
- 批准号:
10457253 - 财政年份:2019
- 资助金额:
$ 28.23万 - 项目类别:
Genome-wide Investigation of cis-splicing between Adjacent Genes
相邻基因之间顺式剪接的全基因组研究
- 批准号:
10217201 - 财政年份:2019
- 资助金额:
$ 28.23万 - 项目类别:
Genome-wide Investigation of cis-splicing between Adjacent Genes
相邻基因之间顺式剪接的全基因组研究
- 批准号:
10006886 - 财政年份:2019
- 资助金额:
$ 28.23万 - 项目类别: